Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisMolecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.Dynamic regulation of serum aryl hydrocarbon receptor agonists in MSImmunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progressionImportance of kynurenine in pulmonary hypertension.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Chromatographic analysis of tryptophan metabolites.Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.NO AUGMENTATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY THROUGH BELATACEPT TREATMENT IN LIVER TRANSPLANT RECIPIENTS.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.
P2860
Q26740330-2DAD556A-6BFB-4BAB-B61B-D41C6C22F132Q28607691-03D67210-6E1C-4DFD-9EB2-7F82B5BB1E4DQ33624653-10E5581F-3E26-440F-878E-8177204D9D04Q33758418-FF113CE4-8D2D-4703-AFCA-95B07995D2C2Q33808285-312D8D3D-55F4-4C16-A609-4ABB84F08E0BQ37342523-CDBD73BB-7324-427C-AF28-1B39DFCE852FQ37623145-35F21B8C-74CD-44D5-96DF-A194CE1A9945Q38680121-69056177-B101-48FE-A923-2178DB6253C1Q38984981-3D805005-27F7-40BE-8997-5D9136DE9F27Q39356675-15DE8EFF-B775-4C86-BFCD-99CD34C06F5BQ42375749-55A37D83-91BD-46C8-83C3-2B6041E8EF2BQ46496773-5F9037E3-6C15-4E73-95AE-47E33D2FC3E1Q47260341-7B4DCA66-906F-4608-ACF9-7F63889034B3Q55381445-C0570EC0-AED0-4DCB-99B0-A7B0A6AAE95C
P2860
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@ast
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@en
type
label
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@ast
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@en
prefLabel
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@ast
Indoleamine 2,3 Dioxygenase (I ...... -Remitting Multiple Sclerosis.
@en
P2093
P2860
P50
P1433
P1476
Indoleamine 2,3 Dioxygenase (I ...... g-Remitting Multiple Sclerosis
@en
P2093
Ambra Hernis
Domenico Caputo
Mario Clerici
P2860
P304
P356
10.1371/JOURNAL.PONE.0130715
P407
P577
2015-06-25T00:00:00Z